Tag Archives: Medtronic

June 2018—Medtronic received FDA approval for its Guardian Connect continuous glucose monitoring system for people with diabetes ages 14 to 75 years.

January 2018—The Society of Toxicologic Pathology invites CAP members to consider a call for papers and contribute to the publication of a special 2019 issue focusing on medical devices in pathology in support of preclinical studies.

Medtronic offers the GenCut core biopsy system, a lung tissue biopsy tool for use with the SuperDimension navigation system, which enables a minimally invasive approach to accessing difficult-to-reach areas of the lung.